SEARCH:   Advanced

Prepublished online as a Blood First Edition Paper on June 19, 2003; DOI 10.1182/blood-2003-01-0211. This Article Full Text Full Text (PDF) All Versions of this Article: 2003-01-0211v1 102/7/2605    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cao, X. Articles by May, W. S. Search for Related Content PubMed PubMed Citation Articles by Cao, X. Articles by May, W. S. Related Collections Neoplasia Apoptosis Signal Transduction Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 October 2003, Vol. 102, No. 7, pp. 2605-2614 NEOPLASIA Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax Xuefang Cao, Xingming Deng, and W. Stratford May From the University of Florida College of Medicine, UF Shands Cancer Center and Department of Medicine, Gainesville. Bax is cleaved by calpain at aspartate 33 (Asp33) to yield p18 Bax during stress-induced apoptosis. To assess the role of p18 Bax in apoptosis, an ecdysone-inducible expression system was generated. Similar levels of wild-type (WT) and noncleavable Asp33Ala (AspAla) Bax are induced in 293 cells while expression of N-terminal-deleted p18 (1-33) Bax remains low (20% of full-length p21 Bax) due to a reduced half-life (2 hours versus 12 hours for p21 Bax) resulting from increased sensitivity to cathepsin-like proteolytic degradation. Expression of p18 Bax is enhanced to levels comparable to p21 Bax when induction is carried out in the presence of cathepsin inhibitors, Z-Phe-Gly-NHO-Bz or N-Acetyl-Leu-Leu-Met-CHO. Compared with WT Bax, expression of similar levels of p18 Bax and, surprisingly, Asp33Ala Bax more potently induces apoptosis as indicated by increased cytochrome c release, caspase-9/-3 activation, and DNA fragmentation, potentially due to their increased homo-oligomerization in mitochondrial membranes. Studies in A-549, U-937, K-562, and HL-60 cells confirm that inhibition of Bax cleavage results in 25% to 35% reduction of drug-induced apoptosis, while inhibition of p18 Bax degradation enhances apoptosis by 25% to 40%. Results indicate that although cleavage to p18 Bax is not required for Bax to initiate apoptosis, p18 Bax potently accelerates the apoptotic process. (Blood. 2003;102:2605-2614) CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. S. Mader, N. Mookherjee, R. E.W. Hancock, and R. C. Bleackley The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity Mol. Cancer Res., May 1, 2009; 7(5): 689 - 702. [Abstract] [Full Text] [PDF] M. Travert, P. Ame-Thomas, C. Pangault, A. Morizot, O. Micheau, G. Semana, T. Lamy, T. Fest, K. Tarte, and T. Guillaudeux CD40 Ligand Protects from TRAIL-Induced Apoptosis in Follicular Lymphomas through NF-{kappa}B Activation and Up-Regulation of c-FLIP and Bcl-xL J. Immunol., July 15, 2008; 181(2): 1001 - 1011. [Abstract] [Full Text] [PDF] X. Cao, R. L. Bennett, and W. S. May c-Myc and Caspase-2 Are Involved in Activating Bax during Cytotoxic Drug-induced Apoptosis J. Biol. Chem., May 23, 2008; 283(21): 14490 - 14496. [Abstract] [Full Text] [PDF] S. Tavolari, M. Bonafe, M. Marini, C. Ferreri, G. Bartolini, E. Brighenti, S. Manara, V. Tomasi, S. Laufer, and T. Guarnieri Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade Carcinogenesis, February 1, 2008; 29(2): 371 - 380. [Abstract] [Full Text] [PDF] A. De Biasio, J. A. Vrana, P. Zhou, L. Qian, C. K. Bieszczad, K. E. Braley, A. M. Domina, S. J. Weintraub, J. M. Neveu, W. S. Lane, et al. N-terminal Truncation of Antiapoptotic MCL1, but Not G2/M-induced Phosphorylation, Is Associated with Stabilization and Abundant Expression in Tumor Cells J. Biol. Chem., August 17, 2007; 282(33): 23919 - 23936. [Abstract] [Full Text] [PDF] M. Yang, S. Wu, X. Su, and W. S. May JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity Blood, December 15, 2006; 108(13): 4136 - 4145. [Abstract] [Full Text] [PDF] M. Xin and X. Deng Protein Phosphatase 2A Enhances the Proapoptotic Function of Bax through Dephosphorylation J. Biol. Chem., July 7, 2006; 281(27): 18859 - 18867. [Abstract] [Full Text] [PDF] X. Deng, F. Gao, T. Flagg, J. Anderson, and W. S. May Bcl2's Flexible Loop Domain Regulates p53 Binding and Survival Mol. Cell. Biol., June 15, 2006; 26(12): 4421 - 4434. [Abstract] [Full Text] [PDF] Y. Tan, N. Dourdin, C. Wu, T. De Veyra, J. S. Elce, and P. A. Greer Ubiquitous Calpains Promote Caspase-12 and JNK Activation during Endoplasmic Reticulum Stress-induced Apoptosis J. Biol. Chem., June 9, 2006; 281(23): 16016 - 16024. [Abstract] [Full Text] [PDF] H. Yasui, T. Hideshima, N. Raje, A. M. Roccaro, N. Shiraishi, S. Kumar, M. Hamasaki, K. Ishitsuka, Y.-T. Tai, K. Podar, et al. FTY720 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Drug Resistance Cancer Res., August 15, 2005; 65(16): 7478 - 7484. [Abstract] [Full Text] [PDF] J. Karlsson, A. Edsjo, S. Pahlman, and H. M. Pettersson Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia Mol. Cancer Ther., July 1, 2005; 4(7): 1128 - 1135. [Abstract] [Full Text] [PDF] R. Contractor, I. J. Samudio, Z. Estrov, D. Harris, J. A. McCubrey, S. H. Safe, M. Andreeff, and M. Konopleva A Novel Ring-Substituted Diindolylmethane,1,1-Bis[3'-(5-Methoxyindolyl)]-1-(p-t-Butylphenyl) Methane, Inhibits Extracellular Signal-Regulated Kinase Activation and Induces Apoptosis in Acute Myelogenous Leukemia Cancer Res., April 1, 2005; 65(7): 2890 - 2898. [Abstract] [Full Text] [PDF] P.-F. Cartron, H. Arokium, L. Oliver, K. Meflah, S. Manon, and F. M. Vallette Distinct Domains Control the Addressing and the Insertion of Bax into Mitochondria J. Biol. Chem., March 18, 2005; 280(11): 10587 - 10598. [Abstract] [Full Text] [PDF] M. Xin and X. Deng Nicotine Inactivation of the Proapoptotic Function of Bax through Phosphorylation J. Biol. Chem., March 18, 2005; 280(11): 10781 - 10789. [Abstract] [Full Text] [PDF] C. S. H. Ng, S. Wan, and A. P. C. Yim Pulmonary ischaemia-reperfusion injury: role of apoptosis Eur. Respir. J., February 1, 2005; 25(2): 356 - 363. [Abstract] [Full Text] [PDF] A. Schinzel, T. Kaufmann, M. Schuler, J. Martinalbo, D. Grubb, and C. Borner Conformational control of Bax localization and apoptotic activity by Pro168 J. Cell Biol., March 29, 2004; 164(7): 1021 - 1032. [Abstract] [Full Text] [PDF] P.-F. Cartron, L. Oliver, P. Juin, K. Meflah, and F. M. Vallette The p18 Truncated Form of Bax Behaves Like a Bcl-2 Homology Domain 3-only Protein J. Biol. Chem., March 19, 2004; 279(12): 11503 - 11512. [Abstract] [Full Text] [PDF]

	Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020